The latest information

Chemical engineer Katerina Leonida embarks on a PhD covering the DC8 project within the GEne Therapy INnovation training network (GET-IN)

Pascale Berthet sharpens Antleron's go-to-market strategy, bolstering its growth trajectory in pharma and biotech

Antleron CEO Jan Schrooten recognized for his scientific work

David Nauwelaers strengthens the development of Antleron’s manufacturing capabilities enabling custom bioprocess scaling and GMP translation

Britt Van Ballaer develops bioreactor systems in support of scalable bioprocesses and next generation therapies

Our Antleron Fellows: a vibrant, multidisciplinary team of scientists

Antleron interns taking part in innovative ATMP developments

Dieter Hauwaerts brings strategic and operational ATMP excellence to the Antleron team

Maarten Sonnaert guides the Antleron team along its innovation-driven growth path

Tommy Heck - the architect of digital twins for advanced therapy bioprocessing

Another year of successful internships at Antleron

Rik Gijsbers brings molecular and cell biology excellence & viral vector expertise for gene therapy

Evan develops monitoring & control for cell-based processes to enable sustainable ATMP manufacturing

Antleron interns taking their first professional steps in the ATMP scene

Reinout Hesselink joins Antleron fellowship to realize a paradigm shift in ATMP manufacturing

Meet Anaïs, our specialist in life, health and drug sciences

Kathleen Coddens does ATMP project experiments for personalized therapy development

Brant Tournoy focuses on 3D printing capabilities in the biotech world

Meet Jeroen Tuttens

A warm welcome to our new fellows